Last reviewed · How we verify
Open Label, Randomized, 3-sequence Crossover Study to Evaluate the Drug-drug Interaction Between Ambroxol HCl and Levodropropizine in Healthy Male Volunteers
The purpose of this study is to evaluate the drug-durg interaction between ambroxol and levodropropizine.
Details
| Lead sponsor | Hanmi Pharmaceutical Company Limited |
|---|---|
| Phase | Phase 1 |
| Status | COMPLETED |
| Enrolment | 21 |
| Start date | 2012-02 |
| Completion | 2012-04 |
Conditions
- Healthy
Interventions
- Ambroxol and Levodropropizine
- Ambroxol
- Levodropropizine
Primary outcomes
- AUClast — 0-48hrs
- Cmax — 0-48hrs
Countries
South Korea